Cargando…

Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems

Acne vulgaris is a common inflammatory pilosebaceous condition that affects 80–90% of adolescents. Since the introduction of tretinoin over 40 years ago, topical retinoid products have been a mainstay of acne treatment. The retinoids are very effective in addressing multiple aspects of the acne path...

Descripción completa

Detalles Bibliográficos
Autores principales: Latter, Gemma, Grice, Jeffrey E., Mohammed, Yousuf, Roberts, Michael S., Benson, Heather A. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835300/
https://www.ncbi.nlm.nih.gov/pubmed/31554188
http://dx.doi.org/10.3390/pharmaceutics11100490
_version_ 1783466639782576128
author Latter, Gemma
Grice, Jeffrey E.
Mohammed, Yousuf
Roberts, Michael S.
Benson, Heather A. E.
author_facet Latter, Gemma
Grice, Jeffrey E.
Mohammed, Yousuf
Roberts, Michael S.
Benson, Heather A. E.
author_sort Latter, Gemma
collection PubMed
description Acne vulgaris is a common inflammatory pilosebaceous condition that affects 80–90% of adolescents. Since the introduction of tretinoin over 40 years ago, topical retinoid products have been a mainstay of acne treatment. The retinoids are very effective in addressing multiple aspects of the acne pathology as they are comedolytic and anti-inflammatory, and do not contribute to antibiotic resistance or microbiome disturbance that can be associated with long-term antibiotic therapies that are a common alternative treatment. However, topical retinoids are associated with skin dryness, erythema and pain, and may exacerbate dermatitis or eczema. Thus, there is a clear need to target delivery of the retinoids to the pilosebaceous units to increase efficacy and minimise side effects in surrounding skin tissue. This paper reviews the current marketed topical retinoid products and the research that has been applied to the development of targeted topical delivery systems of retinoids for acne.
format Online
Article
Text
id pubmed-6835300
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68353002019-11-25 Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems Latter, Gemma Grice, Jeffrey E. Mohammed, Yousuf Roberts, Michael S. Benson, Heather A. E. Pharmaceutics Review Acne vulgaris is a common inflammatory pilosebaceous condition that affects 80–90% of adolescents. Since the introduction of tretinoin over 40 years ago, topical retinoid products have been a mainstay of acne treatment. The retinoids are very effective in addressing multiple aspects of the acne pathology as they are comedolytic and anti-inflammatory, and do not contribute to antibiotic resistance or microbiome disturbance that can be associated with long-term antibiotic therapies that are a common alternative treatment. However, topical retinoids are associated with skin dryness, erythema and pain, and may exacerbate dermatitis or eczema. Thus, there is a clear need to target delivery of the retinoids to the pilosebaceous units to increase efficacy and minimise side effects in surrounding skin tissue. This paper reviews the current marketed topical retinoid products and the research that has been applied to the development of targeted topical delivery systems of retinoids for acne. MDPI 2019-09-24 /pmc/articles/PMC6835300/ /pubmed/31554188 http://dx.doi.org/10.3390/pharmaceutics11100490 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Latter, Gemma
Grice, Jeffrey E.
Mohammed, Yousuf
Roberts, Michael S.
Benson, Heather A. E.
Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems
title Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems
title_full Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems
title_fullStr Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems
title_full_unstemmed Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems
title_short Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems
title_sort targeted topical delivery of retinoids in the management of acne vulgaris: current formulations and novel delivery systems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835300/
https://www.ncbi.nlm.nih.gov/pubmed/31554188
http://dx.doi.org/10.3390/pharmaceutics11100490
work_keys_str_mv AT lattergemma targetedtopicaldeliveryofretinoidsinthemanagementofacnevulgariscurrentformulationsandnoveldeliverysystems
AT gricejeffreye targetedtopicaldeliveryofretinoidsinthemanagementofacnevulgariscurrentformulationsandnoveldeliverysystems
AT mohammedyousuf targetedtopicaldeliveryofretinoidsinthemanagementofacnevulgariscurrentformulationsandnoveldeliverysystems
AT robertsmichaels targetedtopicaldeliveryofretinoidsinthemanagementofacnevulgariscurrentformulationsandnoveldeliverysystems
AT bensonheatherae targetedtopicaldeliveryofretinoidsinthemanagementofacnevulgariscurrentformulationsandnoveldeliverysystems